Abstract: In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process. Aims: The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results: The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.
Informing MS patients on treatment options: a consensus on the process of consent taking / Tortorella, C.; Solaro, C.; Annovazzi, P.; Boffa, L.; Buscarinu, M. C.; Buttari, F.; Calabrese, M.; Cavalla, P.; Cocco, E.; Cordioli, C.; De Luca, G.; Di Filippo, M.; Fantozzi, R.; Ferraro, D.; Gajofatto, A.; Gallo, A.; Lanzillo, R.; Laroni, A.; Fermo, S. L.; Malucchi, S.; Maniscalco, G. T.; Moccia, M.; Nociti, V.; Paolicelli, D.; Pesci, I.; Prosperini, L.; Ragonese, P.; Tomassini, V.; Clerici, V. L. A. T.; Rodegher, M.; Gherardi, M.; Gasperini, C.. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:8(2020), pp. 2249-2253. [10.1007/s10072-020-04339-z]
Informing MS patients on treatment options: a consensus on the process of consent taking
Buscarinu M. C.;Moccia M.;Prosperini L.;Gasperini C.
2020
Abstract
Abstract: In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process. Aims: The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results: The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of Italian Neurological Society (SIN) and constitutes a step toward a standardized decision process around DMTs in MS.| File | Dimensione | Formato | |
|---|---|---|---|
|
Tortorella_Informing MS patients_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
183.31 kB
Formato
Adobe PDF
|
183.31 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
